Search Results - F. T. Ageev

Refine Results
  1. 1
    Modern concept of diastolic heart failure

    Modern concept of diastolic heart failure by F. T. Ageev

    Published 1970-01-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists

    Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists by M. D. Smirnova, F. T. Ageev

    Published 2007-12-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to the ON TIME Observational Study

    Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to... by F. T. Ageev, M. D. Smirnova

    Published 2023-01-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus: pathophysiology and treatment options

    Heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus: pathophysiology and treatment options by A. A. Borisov, A. D. Gvozdeva, F. T. Ageev

    Published 2021-07-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Patient adherence after coronary bypass grafting: different facets of same matter. A systematic review

    Patient adherence after coronary bypass grafting: different facets of same matter. A systematic review by T. V. Fofanova, M. V. Subotnikov, F. Т. Ageev

    Published 2021-08-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Coadministration of Cardiomagnyl with Edarbi/Edarbi Clo in comparison with enteric-coated acetylsalicylic acid and renin-angiotensin-aldosterone system blockers in patients with hypertension and atherosclerotic cardiovascular diseases in the Russian Federation. Results of the CARAT study

    Coadministration of Cardiomagnyl with Edarbi/Edarbi Clo in comparison with enteric-coated acetylsalicylic acid and renin-angiotensin-aldosterone system blockers in patients with hy... by F. T. Ageev, M. D. Smirnova, A. N. Kaftanov, D. V. Gavrilov

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Heart rate reduction as a therapeutic goal: focus on primary prevention

    Heart rate reduction as a therapeutic goal: focus on primary prevention by Yu. A. Orlova, G. V. Makarova, G. V. Mikhailova, F. T. Ageev

    Published 2012-02-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Left ventricular hypertrophy: renin4angiotensin system role

    Left ventricular hypertrophy: renin4angiotensin system role by F. T. Ageev, A. G. Ovchinnikov, V. M. Serbul, Yu. N. Belenkov

    Published 2008-04-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Reproducibility of instantaneous wave-free ratio and angiography coregistration in patients with coronary heart disease and diffuse and multilevel coronary artery lesion

    Reproducibility of instantaneous wave-free ratio and angiography coregistration in patients with coronary heart disease and diffuse and multilevel coronary artery lesion by D. S. Bubnov, R. V. Atanesyan, Z. B. Kardanakhishvili, F. T. Ageev, Yu. G. Matchin

    Published 2023-11-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Guidelines for nurses and patients with chronic heart failure

    Guidelines for nurses and patients with chronic heart failure by S. A. Boytsov, F. T. Ageev, Z. N. Blankova, O. N. Svirida, Yu. L. Begrambekova

    Published 2021-02-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Potential of valsartan+sacubitril therapy in hypertensive heart disease

    Potential of valsartan+sacubitril therapy in hypertensive heart disease by A. G. Ovchinnikov, A. D. Gvozdeva, A. V. Potekhina, M. V. Vitsenya, F. T. Ageev

    Published 2021-08-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Algorithm for predicting cardiovascular events in low/moderate risk patients using traditional and new factors: data from 10-year follow-up study

    Algorithm for predicting cardiovascular events in low/moderate risk patients using traditional and new factors: data from 10-year follow-up study by M. D. Smirnova, O. N. Svirida, T. V. Fofanova, Z. N. Blankova, E. B. Yarovaya, F. T. Ageev

    Published 2021-10-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Improving outpatient care in chronic heart failure

    Improving outpatient care in chronic heart failure by S. A. Boytsov, F. T. Ageev, O. N. Svirida, Z. N. Blankova, Yu. L. Begrambekova, O. M. Reitblat

    Published 2021-08-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART

    ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART by M. D. Smirnova, T. V. Fofanova, Z. B. Khasanova, A. G. Ovchinnikov, F. T. Ageev, A. Yu. Postnov

    Published 2009-04-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Subclinical depression and anxiety as an additional risk factor for cardiovascular events in low- and moderate-risk patients: data from 10-year follow-up

    Subclinical depression and anxiety as an additional risk factor for cardiovascular events in low- and moderate-risk patients: data from 10-year follow-up by M. D. Smirnova, O. N. Svirida, T. V. Fofanova, Z. N. Blankova, E. B. Yarovaya, F. T. Ageev, S. A. Boytsov

    Published 2021-07-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    What “new” factors should be considered when assessing cardiovascular risk?

    What “new” factors should be considered when assessing cardiovascular risk? by M. D. Smirnova, I. V. Barinova, T. V. Fofanova, Z. N. Blankova, O. N. Svirida, F. T. Ageev, S. A. Boytsov

    Published 2018-12-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    EFFICACY OF A FIXED COMBINATION OF LOSARTAN AND AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION: SEASONAL FEATURES

    EFFICACY OF A FIXED COMBINATION OF LOSARTAN AND AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION: SEASONAL FEATURES by M. D. Smirnova, T. V. Fofanova, Z. N. Blankova, M. V. Vitsenya, T. V. Tsybulskaya, Yu. F. Dianova, F. T. Ageev

    Published 2017-06-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    HEALTH EFFECTS OF HOT SUMMER WEATHER IN PATIENTS WITH INTERMEDIATE AND HIGH CARDIOVASCULAR RISK

    HEALTH EFFECTS OF HOT SUMMER WEATHER IN PATIENTS WITH INTERMEDIATE AND HIGH CARDIOVASCULAR RISK by M. D. Smirnova, F. T. Ageev, O. N. Svirida, L. G. Ratova, G. G. Konovalova, A. K. Tikhadze, V. Z. Lankin

    Published 2013-08-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    EVALUATION OF THE SHORT-TERM AND DELAYED RISKS OF THE ABNORMAL SUMMER 2010 HEAT IMPACT IN SEVERAL DISTRICTS OF NIZHNY NOVGOROD OBLAST, CLOSE TO WILDFIRES, ON THE MORBIDITY AND MORTALITY OF INHABITANTS

    EVALUATION OF THE SHORT-TERM AND DELAYED RISKS OF THE ABNORMAL SUMMER 2010 HEAT IMPACT IN SEVERAL DISTRICTS OF NIZHNY NOVGOROD OBLAST, CLOSE TO WILDFIRES, ON THE MORBIDITY AND MORT... by M. D. Smirnova, Yu. V. Badin, O. Yu. Badina, A. R. Vaisberg, D. S. Polyakov, E. V. Shcherbinina, F. T. Ageev, F. T. Fomin

    Published 2015-12-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation

    Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation by F. T. Ageev, A. G. Ovchinnikov, A. G. Plisyuk, N. E. Arzamastseva, B. D. Kulev, A. E. Kuz’mina, I. F. Patrusheva

    Published 2011-06-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: